Avidity Biosciences Correlations
| RNA Stock | USD 30.84 0.01 0.03% |
The current 90-days correlation between Avidity Biosciences and Revolution Medicines is 0.37 (i.e., Weak diversification). The correlation of Avidity Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Avidity Biosciences Correlation With Market
Weak diversification
The correlation between Avidity Biosciences and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Avidity Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Avidity |
Moving against Avidity Stock
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Avidity Stock performing well and Avidity Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Avidity Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TCRR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| RVMD | 1.71 | (0.16) | 0.00 | (0.20) | 0.00 | 4.37 | 11.35 | |||
| BDTX | 3.94 | (0.29) | 0.00 | (0.21) | 0.00 | 7.09 | 29.04 | |||
| BCEL | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| PASG | 4.19 | (0.30) | 0.00 | (0.29) | 0.00 | 7.69 | 56.48 | |||
| AKRO | 4.30 | 1.28 | 0.36 | 0.70 | 2.89 | 4.92 | 104.81 | |||
| PTGX | 2.79 | 0.42 | 0.22 | (0.35) | 2.47 | 3.48 | 50.66 | |||
| STOK | 3.45 | (0.39) | 0.00 | (0.32) | 0.00 | 7.03 | 20.29 | |||
| IGMS | 4.81 | (1.80) | 0.00 | (0.85) | 0.00 | 5.64 | 71.93 | |||
| CERE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Avidity Biosciences Corporate Management
| Kathleen Gallagher | Chief Officer | Profile | |
| Teresa McCarthy | Chief Officer | Profile | |
| Eric Mosbrooker | Chief Officer | Profile | |
| III JD | Consultant | Profile | |
| Michael CPA | Chief Officer | Profile | |
| Michael MacLean | Chief Officer | Profile |